Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 755 across all filing types
Latest filing 2018-08-16 AGM Information
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Pacific Edge 2018 Annual Meeting of Shareholders
AGM Information Classification · 95% confidence The document is a detailed transcript of an Annual Meeting of Shareholders held on 16 August 2018. It includes presentations by the Chairman and CEO, introductions of board members, discussion of financial results for the fiscal year ended 31 March 2018, capital raising activities, strategic outlook, and operational milestones. The content is typical of materials presented at an Annual General Meeting (AGM), including shareholder voting, board changes, and company performance updates. The document is not a full Annual Report (10-K) or an Earnings Release (ER), but rather the meeting materials and presentations shared during the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2018-08-16 English
Another NZ Public Healthcare Providers Adopts Cxbladder
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 16 August 2018 from Pacific Edge Limited, describing the adoption of their Cxbladder testing by a New Zealand public healthcare provider. The content focuses on product information, commercial adoption, and clinical benefits of the diagnostic tests. There are no financial statements, regulatory filings, voting results, or management changes discussed. The document is promotional and informative about a commercial development rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the nature and content, the best fitting category is a general company announcement, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2018-08-15 English
Another NZ Public Healthcare Provider Signs Up to Cxbladder
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 14 August 2018 from Pacific Edge Limited, describing a new healthcare provider adopting their cancer diagnostic tests. It is a press release style announcement about a commercial agreement and product adoption, with no financial data, regulatory filings, or detailed financial reports included. The content focuses on business development and product information rather than financial results or governance. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is a general company announcement about a commercial update, which best fits under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2018-08-14 English
Notice of Change in Issued Capital Stock- Ordinary Shares
Share Issue/Capital Change Classification · 100% confidence The document is titled 'NOTICE OF CHANGE IN ISSUED CAPITAL STOCK - ORDINARY SHARES' and details the issuance of new ordinary shares by Pacific Edge Limited, including the number of shares issued, issue price, and total issued capital before and after the issuance. It references compliance with NZX Listing Rule 7.3.5 and includes specifics about the share issue such as payment in cash and authority for the issue. The document is short (1321 characters) and focuses solely on the announcement of a share issuance event, not a full financial report or detailed analysis. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full capital update or financial report.
2018-07-30 English
PEB Attracts US Investment and Undertakes Share Placement
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 30 July 2018 regarding Pacific Edge Limited attracting a US investment and undertaking a share placement. It details the investment amount, share issuance, and strategic comments from company executives. The content focuses on financing activities, specifically a share placement and capital raising from a US fund. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is about a capital raising event and share issuance rather than a full financial report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7130 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2018-07-29 English
Notice of Annual Shareholders Meeting
AGM Information Classification · 95% confidence The document is an invitation and notice for the Annual Shareholders' Meeting of Pacific Edge Limited, detailing the meeting agenda, resolutions to be voted on (including director re-election, auditor remuneration, and director fee increases), and instructions for shareholders on how to attend and vote. It includes explanatory notes about the resolutions and company governance matters related to the meeting. There is no detailed financial data or full financial performance report included, nor is it a transcript or presentation. The document is clearly related to the Annual General Meeting (AGM) and contains materials typically shared with shareholders prior to or at the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (15,000 characters) and content confirm it is the meeting notice and related information, not just an announcement of a report or a proxy solicitation. Hence, the classification is AGM-R with high confidence.
2018-07-18 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.